EdwardSkolnikMD

Chronic Renal Failure & Dialysis, Glomerular Disease, Renal Metabolism

Professor, Medicine, New York University School of Medicine

Dr. Skolnik is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
560 1st Ave
# Tisch
New York, NY 10016
Phone+1 212-263-5654

Fax+1 212-263-3110

New York Presbyterian Hospital (Cornell Campus)Fellowship, Nephrology, 1986 - 1988
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1982 - 1985
State University of New York Downstate Medical Center College of MedicineClass of 1982

PubMed

152 citations
The SH2 and SH3 domain-containing Nck protein is oncogenic and a common target for phosphorylation by different surface receptors.
W. Li, Patrick J. Hu, Edward Y. Skolnik, A Ullrich, Joseph Schlessinger
Molecular and Cellular Biology. 1992-12-01
694 citations
Advanced glycosylation end products in patients with diabetic nephropathy.
Zenji Makita, Steven Radoff, Elliot J. Rayfield, Zhi Yang, Edward Y. Skolnik
The New England Journal of Medicine. 1991-09-19
121 citations
Inhibition of the K+ channel KCa3.1 ameliorates T cell–mediated colitis
Lie Di, Shekhar Srivastava, Olga Zhdanova, Yi Ding, Zhai Li
Proceedings of the National Academy of Sciences of the United States of America. 2010-01-26